CASTLE BIOSCIENCES INC - Common Stock (CSTL) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2019 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
CSTL on Nasdaq
Shares outstanding
29,328,179
Price per share
$38.90
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
26,525,689
Total reported value
$603,808,452
% of total 13F portfolios
0%
Share change
-49,331
Value change
+$704,746
Number of holders
170
Price from insider filings
$38.90
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CASTLE BIOSCIENCES INC - Common Stock (CSTL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.2% $47,017,281 2,338,005 BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 6.5% $36,852,279 1,832,535 The Vanguard Group 31 Dec 2024
Portolan Capital Management, LLC 5.6% $32,399,201 1,611,099 Portolan Capital Management, LLC 07 Apr 2025
DIMENSIONAL FUND ADVISORS LP 3.9% -24% $44,494,010 -$12,848,347 1,143,799 -22% Dimensional Fund Advisors LP 31 Dec 2025
WASATCH ADVISORS LP 3.5% $20,078,930 998,455 WASATCH ADVISORS LP 31 Mar 2025

As of 30 Sep 2025, 170 institutional investors reported holding 26,525,689 shares of CASTLE BIOSCIENCES INC - Common Stock (CSTL). This represents 90% of the company’s total 29,328,179 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CASTLE BIOSCIENCES INC - Common Stock (CSTL) together control 71% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 11% 3,189,896 +1.1% 0% $72,633,931
VANGUARD GROUP INC 7.4% 2,172,318 +0.11% 0% $49,463,681
PRINCIPAL FINANCIAL GROUP INC 6.1% 1,794,355 -0.26% 0.02% $40,857,463
Portolan Capital Management, LLC 5.2% 1,515,111 +1.7% 1.9% $34,499,077
DIMENSIONAL FUND ADVISORS LP 5% 1,474,089 +7% 0.01% $33,564,113
Nuveen, LLC 3.3% 957,081 -11% 0.01% $21,792,735
BRAIDWELL LP 2.8% 822,735 0% 0.56% $18,733,676
STATE STREET CORP 2.5% 724,080 +2.3% 0% $16,487,302
AIGH Capital Management LLC 2.4% 707,287 5.6% $16,104,925
GEODE CAPITAL MANAGEMENT, LLC 2.4% 698,610 +1.3% 0% $15,909,607
WASATCH ADVISORS LP 2.3% 669,120 -36% 0.08% $15,235,862
Allianz Asset Management GmbH 2.2% 648,351 -9.2% 0.02% $14,762,953
PALISADE CAPITAL MANAGEMENT, LP 2.2% 638,656 +11% 0.4% $14,542,197
MILLENNIUM MANAGEMENT LLC 2% 575,089 +34% 0.01% $13,094,777
RENAISSANCE TECHNOLOGIES LLC 1.9% 562,600 -16% 0.02% $12,810,402
SCHRODER INVESTMENT MANAGEMENT GROUP 1.7% 494,950 -24% 0.01% $11,067,082
Parkman Healthcare Partners LLC 1.6% 475,568 +35% 1.2% $10,828,683
ACADIAN ASSET MANAGEMENT LLC 1.5% 451,652 -17% 0.02% $10,281,000
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 1.4% 400,000 0.3% $9,108,000
SILVERCREST ASSET MANAGEMENT GROUP LLC 1.3% 367,888 +31% 0.06% $8,376,810
GOLDMAN SACHS GROUP INC 1.2% 345,099 +26% 0% $7,857,904
Point72 Asset Management, L.P. 1.1% 336,958 0.02% $7,672,533
Connor, Clark & Lunn Investment Management Ltd. 1.1% 335,891 +166% 0.02% $7,648,238
BANK OF AMERICA CORP /DE/ 1.1% 315,370 -18% 0% $7,180,975
UBS Group AG 0.99% 291,362 -20% 0% $6,634,313

Institutional Holders of CASTLE BIOSCIENCES INC - Common Stock (CSTL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 227,453 $8,791,024 -$362,002 $38.90 13
2025 Q3 26,525,689 $603,808,452 +$704,746 $22.77 170
2025 Q2 26,536,136 $541,803,165 +$16,367,707 $20.42 151
2025 Q1 25,785,418 $516,159,447 -$22,608,207 $20.02 180
2024 Q4 26,505,010 $706,396,254 +$8,987,296 $26.65 197
2024 Q3 25,823,597 $736,872,924 +$15,687,154 $28.52 185
2024 Q2 25,237,547 $549,387,569 +$5,246,303 $21.77 158
2024 Q1 24,977,542 $553,239,171 +$24,692,740 $22.15 148
2023 Q4 23,883,435 $515,429,989 +$17,867,692 $21.58 150
2023 Q3 23,151,664 $391,032,725 +$7,780,165 $16.89 133
2023 Q2 22,797,205 $312,778,898 -$3,698,099 $13.72 128
2023 Q1 22,094,408 $501,938,865 +$5,568,015 $22.72 148
2022 Q4 22,279,170 $524,435,055 +$5,715,957 $23.54 152
2022 Q3 21,906,465 $571,186,085 -$14,799,148 $26.08 152
2022 Q2 22,558,449 $495,033,707 -$115,268,932 $21.95 141
2022 Q1 22,780,568 $1,019,269,661 +$62,738,499 $44.86 153
2021 Q4 21,449,510 $918,308,511 -$59,908,643 $42.87 153
2021 Q3 20,974,973 $1,396,164,362 +$40,585,506 $66.50 182
2021 Q2 20,801,213 $1,521,315,172 -$4,483,937 $73.33 176
2021 Q1 21,328,263 $1,459,495,488 +$90,506,347 $68.46 173
2020 Q4 19,063,994 $1,280,953,552 +$376,683,100 $67.15 160
2020 Q3 13,395,783 $689,395,356 +$88,062,594 $51.45 144
2020 Q2 11,747,525 $443,283,646 +$169,050,988 $37.69 125
2020 Q1 7,359,714 $219,391,385 +$66,312,670 $29.81 88
2019 Q4 5,108,808 $175,588,000 +$15,879,309 $34.37 66
2019 Q3 4,868,946 $88,077,000 +$69,427,000 $18.09 56